Review, 2003
What treatments have been developed for PMS and PMDD?
Over 40 years, hundreds of compounds have been patented for PMS and PMDD, including hormone therapies, antidepressants, vitamins, minerals, supplements, and newer drugs affecting brain chemistry.
What they did
Historical review of patent filings from 1963 onward for treatments of premenstrual syndrome and premenstrual dysphoric disorder.
What they found
Approximately 5-8 percent of women report premenstrual symptoms severe enough to impair daily function and suffer from PMDD, with many more reporting milder PMS symptoms. Hundreds of patented treatments include hormone-based therapies, serotonergic drugs (antidepressants), vitamins and minerals, dietary supplements, compounds with GABAergic activity, and gonadotropin-releasing hormone antagonists.
What it means for you
Many treatment options exist for PMS and PMDD, reflecting evolving understanding of these disorders. This is a review of patents, not clinical evidence of how well these treatments actually work.
5-8%
women with PMDD
About the study
- Original title
- Therapeutic patents for the treatment of premenstrual syndrome and premenstrual dysphoric disorder: historical perspectives and future directions
- Authors
- Lori E. Ross, Meir S Steiner
- Journal
- Expert Opinion on Therapeutic Patents
- Year
- 2003
- Study design
- Review
- What was tested
- Various treatments for PMS and PMDD
- Read the paper
- doi.org/10.1517/13543776.13.10.1491
Topics
Related studies
Systematic review, 2024
What are the best treatments for PMDD and PMS?
Guideline, 2023
How are GnRH agonists used to treat PMDD that doesn't respond to standard medications?
Review, 2022
What causes severe PMS and what treatments work?
Systematic review, 2022
What are the best treatments for PMDD and PMS?
Review, 2018
What are the most effective treatments for premenstrual syndrome and PMDD?
Review, 2015
What do we know about PMS and PMDD and how are they treated?